Combined surgical and medical treatment of giant prolactinoma: case report

Abstract

The operative management of giant pituitary prolactinoma represents a significant challenge for neurosurgeons, due to the degree of local tumor infiltration into adjacent structures such as cavernous sinus. The degree of parasellar tumor extension can be classified according to the Knosp grading system’ while suprasellar extension is qualified in accordance with the modified Hardys classification system. This report describes the case of a male patient with a giant pituitary prolactinoma in which a partial tumor resection via a subfrontal approach was achieved. Typically, resection rates of less than 50% have been reported following surgery on giant pituitary adenomas. Prolactin levels were very high, consistent with invasive giant prolactinoma. Our patient was treated with Cabergoline which eventually normalized the prolactin level and significantly reduced the size of the residual tumor. This case serves to illustrate that in the presence of significant suprasellar and parasellar extension, multi-modal treatment strategies with surgery and dopamine agonist, is the gold standard in the management of locally aggressive pituitary prolactinomas.

Pituitary adenomas: current principles of diagnosis and treatment

“…Эффективность хирургического лечения микропролактином, определяемая по нормализации уровня пролактина в раннем послеоперационном периоде, по данным ряда исследований, достигает 83 % при 10 % частоте рецидивов, что в целом обеспечивает 75 % случаев успешного лечения в долгосрочной перспективе [103]. Лечение гигантских пролактином может включать не только медикаментозную терапию, но и хирургический этап, особенно при резистентных опухолях и необходимости декомпрессии зрительных нервов или разрешения гидроцефалии [104].…”